Oddity Tech .(ODD)

Search documents
Oddity Tech (ODD) Q1 Earnings and Revenues Beat Estimates
ZACKS· 2025-04-29 22:40
Core Viewpoint - Oddity Tech reported quarterly earnings of $0.69 per share, exceeding the Zacks Consensus Estimate of $0.63 per share, and showing an increase from $0.61 per share a year ago, indicating a 9.52% earnings surprise [1][2] Financial Performance - The company achieved revenues of $268.08 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 2.86%, and up from $211.63 million year-over-year [2] - Over the last four quarters, Oddity Tech has consistently surpassed consensus EPS and revenue estimates [2] Stock Performance - Oddity Tech shares have increased approximately 7.2% since the beginning of the year, contrasting with a -6% decline in the S&P 500 [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.87 on revenues of $231.98 million, and for the current fiscal year, it is $1.95 on revenues of $782.57 million [7] - The estimate revisions trend for Oddity Tech is currently unfavorable, resulting in a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Industry Context - The Internet - Software industry, to which Oddity Tech belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8]
Oddity Tech soars 15% after it raises outlook despite tariff threat
CNBC· 2025-04-29 20:28
Core Viewpoint - Oddity Tech is raising its earnings and profit guidance for fiscal 2025 despite anticipated tariff impacts, indicating strong growth and resilience in the retail sector [1][2]. Financial Performance - The company reported a net income of $37.8 million, or 63 cents per share, for the fiscal first quarter, an increase from $33 million, or 53 cents per share, a year earlier [3]. - Sales rose to $268 million, reflecting a 27% increase from $212 million a year prior [4]. - Oddity expects revenue for the current fiscal year to be between $790 million and $798 million, up from a previous range of $776 million to $785 million, exceeding analyst expectations of $784 million [4]. - Adjusted earnings per share are projected to be between $1.99 and $2.04, compared to the prior range of $1.94 to $1.98, also ahead of the $1.93 expected by analysts [5]. Margin and EBITDA Outlook - The company anticipates a gross margin of 71% for fiscal 2025, an increase from the previous forecast of 70% [6]. - Adjusted EBITDA is expected to be between $157 million and $161 million, up from the prior outlook of $155 million to $158 million [6]. Future Projections - For the current quarter, Oddity expects revenue between $235 million and $239 million, surpassing estimates of $232 million [7]. - Adjusted earnings are projected to be between 85 cents and 89 cents per share, ahead of the 84 cents estimate [7]. Industry Context - Oddity Tech stands out in the retail industry, which is facing challenges due to tariffs, as it maintains a focus on growth rather than cost-cutting [9]. - The beauty industry is perceived as resilient during economic downturns, as consumers may opt for beauty products over higher-ticket items [9]. - Oddity's stock has increased by 11% this year, outperforming the S&P 500's 5.4% loss [9].
Oddity Tech .(ODD) - 2025 Q1 - Quarterly Report
2025-04-29 20:14
[Executive Summary & Highlights](index=1&type=section&id=ExecutiveSummaryHighlights) [CEO & CFO Commentary](index=1&type=section&id=CEO_CFO_Commentary) ODDITY's CEO and CFO expressed strong satisfaction with Q1 2025 results, which exceeded expectations across all metrics, leading to a raised full-year outlook. They highlighted the ongoing industry transformation towards online and high-performance products, ODDITY's early investments, and a powerful financial model - Q1 **2025** results exceeded expectations across all metrics, allowing ODDITY to raise its full-year outlook[4](index=4&type=chunk)[5](index=5&type=chunk) - The beauty industry is transforming with consumers moving online and towards high-performance products, which strengthens ODDITY's market opportunity[4](index=4&type=chunk) - Early and aggressive investments in industry transformation enable a powerful financial model, allowing ODDITY to beat guidance and consistently raise its outlook[4](index=4&type=chunk) [Q1 2025 Financial Highlights](index=1&type=section&id=Q1_2025_Financial_Highlights) ODDITY reported robust financial performance for Q1 2025, with significant year-over-year growth in net revenue, gross profit, and net income, alongside strong cash flow generation and a healthy balance sheet with no outstanding debt Q1 2025 Key Financial Highlights | Metric | Q1 2025 | Q1 2024 | YoY Change | | :--------------------- | :---------- | :---------- | :--------- | | Net Revenue | $268 million | $212 million | +27% | | Gross Profit | $201 million | $156 million | +29% | | Gross Margin | 74.9% | 73.8% | +116 bps | | Adjusted EBITDA | $52 million | $48 million | +9% | | Net Income | $38 million | $33 million | +15.2% | | Adjusted Net Income | $42 million | $38 million | +10.5% | | Operating Cash Flow | $88 million | $79.6 million | +10.5% | | Free Cash Flow | $87 million | $79 million | +10.1% | | Diluted EPS | $0.63 | $0.53 | +18.9% | | Adjusted Diluted EPS | $0.69 | $0.61 | +13.1% | | Cash & Investments (as of Mar 31, 2025) | $257 million | N/A | N/A | | Outstanding Debt (as of Mar 31, 2025) | $0 | N/A | N/A | [Q1 2025 Operational Highlights](index=1&type=section&id=Q1_2025_Operational_Highlights) ODDITY achieved several operational milestones in Q1 2025, including double-digit revenue growth for both IL MAKIAGE and SpoiledChild, accelerated international expansion, progress on Brand 3, and ongoing development of its molecule discovery platform - Achieved double-digit revenue growth for both IL MAKIAGE and SpoiledChild brands[7](index=7&type=chunk) - Accelerated international expansion efforts[7](index=7&type=chunk) - Progressed Brand 3 towards a planned soft launch in Q3 **2025** and formal launch in Q4 **2025**[7](index=7&type=chunk) - Continued development and expansion of the ODDITY LABS molecule discovery platform[7](index=7&type=chunk) [Q1 2025 Actual Results vs. Guidance](index=3&type=section&id=Q1_2025_Actual_Results_vs_Guidance) ODDITY's actual financial results for Q1 2025 surpassed its own guidance across all key metrics, including net revenue, gross margin, adjusted EBITDA, and adjusted diluted EPS Q1 2025 Actual Results vs. Guidance | Metric | Actual Results | Guidance Low End | Guidance High End | | :----------------- | :------------- | :--------------- | :---------------- | | Net Revenue | $268 million | $258 million | $262 million | | Gross Margin | 74.9% | 72.0% | 72.0% | | Adjusted EBITDA | $52 million | $49 million | $50 million | | Adjusted Diluted EPS | $0.69 | $0.61 | $0.63 | [Financial Outlook](index=3&type=section&id=FinancialOutlook) [Full Year 2025 Outlook](index=3&type=section&id=Full_Year_2025_Outlook) ODDITY raised its full-year 2025 financial outlook across all metrics, now expecting revenue growth ahead of its 20% long-term algorithm, despite anticipating manageable tariff and trade-related headwinds - ODDITY raised its **2025** financial outlook across all metrics, expecting revenue growth to exceed its **20%** long-term algorithm[11](index=11&type=chunk)[13](index=13&type=chunk) - Tariff and trade-related headwinds are expected to be manageable and largely offset by cost efficiencies in **2025** and **2026**[12](index=12&type=chunk) Current vs. Prior Full Year 2025 Outlook | Metric | Current FY2025 Outlook | Prior FY2025 Outlook | | :----------------- | :--------------------- | :------------------- | | Net Revenue | $790-798 million (22-23% YoY growth) | $776-785 million | | Gross Margin | 71% | 70% | | Adjusted EBITDA | $157-161 million | $155-158 million | | Adjusted Diluted EPS | $1.99-2.04 | $1.94-1.98 | [Second Quarter 2025 Guidance](index=3&type=section&id=Second_Quarter_2025_Guidance) ODDITY provided guidance for the second quarter ending June 30, 2025, projecting strong year-over-year revenue growth and healthy profitability metrics Q2 2025 Guidance | Metric | Q2 2025 Outlook | | :----------------- | :---------------- | | Net Revenue | $235-239 million (22-24% YoY growth) | | Gross Margin | 70.5% | | Adjusted EBITDA | $65-68 million | | Adjusted Diluted EPS | $0.85-0.89 | [Additional Information](index=5&type=section&id=AdditionalInformation) [Conference Call Details](index=5&type=section&id=Conference_Call_Details) ODDITY scheduled a conference call for April 30, 2025, to discuss Q1 2025 financial and business results and outlook, with details provided for participation and webcast access - A conference call is scheduled for April **30**, **2025**, at **8:30** a.m. ET to discuss Q1 **2025** financial and business results and outlook[19](index=19&type=chunk) - Dial-in numbers and webcast access details are provided for participation and replay[19](index=19&type=chunk) [Non-GAAP Financial Measures](index=5&type=section&id=Non_GAAP_Financial_Measures) ODDITY utilizes several non-GAAP financial measures, including Adjusted EBITDA, Adjusted net income, and free cash flow, to provide supplemental information for evaluating business performance and trends, with clear definitions for each measure and its purpose - ODDITY uses non-GAAP financial measures (Adjusted EBITDA, Adjusted net income, free cash flow) to provide useful supplemental information for evaluating its business, performance, and trends[20](index=20&type=chunk) - Adjusted EBITDA is defined as net income before financial income, taxes, depreciation, amortization, share-based compensation expense, and non-recurring items[21](index=21&type=chunk) - Adjusted net income is defined as net income adjusted for share-based compensation, non-recurring items, one-time tax gains/losses, and the tax effect of non-GAAP adjustments; Adjusted diluted EPS is Adjusted net income divided by diluted shares outstanding[22](index=22&type=chunk) - Free cash flow is defined as net cash provided by operating activities less purchase of property and equipment[23](index=23&type=chunk) [Forward-Looking Statements & Risk Factors](index=6&type=section&id=Forward_Looking_Statements_Risk_Factors) The report contains forward-looking statements regarding ODDITY's future performance and outlook, which are inherently subject to various risks and uncertainties, including market trends, competition, supply chain disruptions, regulatory changes, and geopolitical factors - The press release includes forward-looking statements concerning ODDITY's business strategy, market opportunity, product delivery, long-term success, and financial outlook for Q2 and FY**2025**[24](index=24&type=chunk) - These statements are subject to risks and uncertainties such as maintaining brand value, responding to market trends, customer acquisition/retention, supply chain issues, demand forecasting, competition, raw material costs, counterfeiting, shipping disruptions, growth management, economic downturns, new product introduction, currency fluctuations, regulatory compliance, product liability, trade restrictions, tariffs, data breaches, intellectual property, and geopolitical conflicts[24](index=24&type=chunk) [About ODDITY](index=7&type=section&id=About_ODDITY) ODDITY is a consumer tech company that builds and scales digital-first beauty and wellness brands, leveraging an AI-driven online platform to identify consumer needs and develop solutions, serving approximately 60 million users through brands like IL MAKIAGE and SpoiledChild - ODDITY is a consumer tech company focused on building and scaling digital-first brands in the beauty and wellness industries[25](index=25&type=chunk) - The company utilizes an AI-driven online platform and data science to identify consumer needs, serving approximately **60 million** users[25](index=25&type=chunk) - ODDITY owns IL MAKIAGE and SpoiledChild, with business headquarters in New York City, an R&D center in Tel Aviv, and a biotechnology lab in Boston[25](index=25&type=chunk) [Contacts](index=7&type=section&id=Contacts) Contact information for press and investor inquiries is provided - Contact details for press (Michael Braun) and investor relations are provided[26](index=26&type=chunk) [Consolidated Financial Statements](index=8&type=section&id=ConsolidatedFinancialStatements) [Consolidated Statements of Income](index=8&type=section&id=Consolidated_Statements_of_Income) The consolidated statements of income detail ODDITY's financial performance for the three months ended March 31, 2025, compared to the same period in 2024, outlining net revenue, cost of revenue, gross profit, operating expenses, and net income Consolidated Statements of Income (Three months ended March 31, USD in thousands) | Metric | 2025 | 2024 | | :------------------------ | :----- | :----- | | Net revenue | $268,076 | $211,628 | | Cost of revenue | $67,228 | $55,522 | | Gross profit | $200,848 | $156,106 | | Selling, general and administrative | $158,183 | $117,125 | | Operating income | $42,665 | $38,981 | | Financial income, net | $(2,647) | $(2,955) | | Income before taxes on income | $45,312 | $41,936 | | Taxes on income | $7,481 | $8,953 | | Net income | $37,831 | $32,983 | | Basic earnings per share | $0.68 | $0.57 | | Diluted earnings per share | $0.63 | $0.53 | [Consolidated Balance Sheets](index=9&type=section&id=Consolidated_Balance_Sheets) The consolidated balance sheets present ODDITY's financial position as of March 31, 2025, compared to December 31, 2024, providing a detailed breakdown of current and long-term assets, liabilities, and shareholders' equity Consolidated Balance Sheets (USD in thousands) | ASSETS | March 31, 2025 | December 31, 2024 | | :-------------------------------- | :--------------- | :------------------ | | **CURRENT ASSETS:** | | | | Cash and cash equivalents | $136,860 | $50,340 | | Short-term deposits | $48,000 | $48,000 | | Marketable securities | $1,799 | $1,880 | | Trade receivables | $13,477 | $9,188 | | Inventories | $96,256 | $99,810 | | Prepaid expenses and other current assets | $18,852 | $14,151 | | **Total current assets** | **$315,244** | **$223,369** | | **LONG-TERM ASSETS:** | | | | Marketable securities | $70,034 | $68,831 | | Property, plant and equipment, net | $10,114 | $9,817 | | Deferred tax asset, net | $9,279 | $8,786 | | Intangible assets, net | $36,636 | $36,458 | | Goodwill | $64,904 | $64,904 | | Operating lease right-of-use assets | $24,762 | $23,567 | | Other assets | $3,268 | $3,150 | | **Total long-term assets** | **$218,997** | **$215,513** | | **Total assets** | **$534,241** | **$438,882** | | **LIABILITIES AND SHAREHOLDERS' EQUITY** | | | | **CURRENT LIABILITIES:** | | | | Trade payables | $120,772 | $79,130 | | Other accounts payable and accrued expenses | $41,422 | $38,566 | | Operating lease liabilities, current | $7,322 | $7,106 | | **Total current liabilities** | **$169,516** | **$124,802** | | **LONG-TERM LIABILITIES:** | | | | Operating lease liabilities, non-current | $16,352 | $15,604 | | Other long-term liabilities | $18,637 | $16,172 | | **Total liabilities** | **$204,505** | **$156,578** | | **SHAREHOLDERS' EQUITY:** | | | | Class A Ordinary shares | $14 | $14 | | Class B Ordinary shares | $3 | $3 | | Additional paid-in capital | $86,315 | $76,912 | | Accumulated other comprehensive income | $2,304 | $2,106 | | Retained earnings | $241,100 | $203,269 | | **Total shareholders' equity** | **$329,736** | **$282,304** | | **Total liabilities and shareholders' equity** | **$534,241** | **$438,882** | [Consolidated Statements of Cash Flows](index=11&type=section&id=Consolidated_Statements_of_Cash_Flows) The consolidated statements of cash flows detail ODDITY's cash movements from operating, investing, and financing activities for the three months ended March 31, 2025, compared to the same period in 2024, showing a significant net increase in cash and equivalents Consolidated Statements of Cash Flows (Three months ended March 31, USD in thousands) | Cash Flows From | 2025 | 2024 | | :------------------------------------------ | :----- | :----- | | Net cash provided by operating activities | $88,336 | $79,647 | | Net cash used in investing activities | $(3,961) | $(47,099) | | Net cash provided by financing activities | $1,931 | $6,431 | | Effect of exchange rate fluctuations on cash | $284 | $(127) | | Net increase in cash, cash equivalents and restricted cash | $86,590 | $38,852 | | Cash, cash equivalents and restricted cash at beginning of period | $50,347 | $38,766 | | Cash, cash equivalents and restricted cash at end of period | $136,937 | $77,618 | [Reconciliations & Supplemental Data](index=12&type=section&id=ReconciliationsSupplementalData) [Reconciliation of GAAP to Non-GAAP Financial Information](index=12&type=section&id=Reconciliation_of_GAAP_to_Non_GAAP_Financial_Information) This section provides detailed reconciliations of GAAP net income to Adjusted EBITDA and Adjusted net income, outlining the specific adjustments made for non-GAAP reporting, such as share-based compensation and tax adjustments Reconciliation of Net Income and Adjusted EBITDA (Three months ended March 31, USD in thousands) | Metric | 2025 | 2024 | | :------------------------ | :----- | :----- | | Net Income | $37,831 | $32,983 | | Financial income, net | $(2,647) | $(2,955) | | Taxes on Income | $7,481 | $8,953 | | Depreciation and amortization | $2,655 | $2,301 | | Share-based compensation | $7,084 | $6,862 | | **Adjusted EBITDA** | **$52,404** | **$48,144** | Reconciliation of Net Income and Adjusted Net Income (Three months ended March 31, USD in thousands) | Metric | 2025 | 2024 | | :------------------------ | :----- | :----- | | Net Income | $37,831 | $32,983 | | Share-based compensation | $7,084 | $6,862 | | Tax adjustments | $(3,106) | $(1,465) | | **Adjusted Net Income** | **$41,809** | **$38,380** | | Diluted earnings per share | $0.63 | $0.53 | | **Adjusted diluted earnings per share** | **$0.69** | **$0.61** | [Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow](index=12&type=section&id=Reconciliation_of_Net_Cash_Provided_by_Operating_Activities_to_Free_Cash_Flow) This section reconciles net cash provided by operating activities to free cash flow for the three months ended March 31, 2025 and 2024, by deducting purchases of property and equipment Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow (Three Months Ended March 31, USD in thousands) | Metric | 2025 | 2024 | | :------------------------------------ | :----- | :----- | | Net operating cash flow | $88,336 | $79,647 | | Purchase of property and equipment | $(1,002) | $(655) | | **Free cash flow** | **$87,334** | **$78,992** | [Cash, Cash Equivalents, and Investments](index=12&type=section&id=Cash_Cash_Equivalents_and_Investments) This section provides a breakdown of ODDITY's cash, cash equivalents, and investments as of March 31, 2025, and December 31, 2024, showing a significant increase in total cash and investments Cash, Cash Equivalents, and Investments (USD in thousands) | Metric | March 31, 2025 | December 31, 2024 | | :-------------------------- | :--------------- | :------------------ | | Cash and cash equivalents | $136,860 | $50,340 | | Short-term deposits and restricted cash | $48,077 | $48,007 | | Marketable securities | $71,833 | $70,711 | | **Total cash and investments** | **$256,770** | **$169,058** | [Net Revenue by Sales Channel](index=13&type=section&id=Net_Revenue_by_Sales_Channel) This section details ODDITY's net revenue breakdown by sales channel for the three months ended March 31, 2025, and 2024, highlighting the continued dominance of online direct-to-consumer sales Net Revenue by Sales Channel (Three Months Ended March 31, USD in thousands) | Sales Channel | 2025 | Percent of Net Revenue (2025) | 2024 | Percent of Net Revenue (2024) | | :------------------------------ | :----- | :---------------------------- | :----- | :---------------------------- | | Online direct-to-consumer | $261,053 | 97% | $203,575 | 96% | | Other (Israel retail, marketing affiliates) | $7,023 | 3% | $8,053 | 4% | | **Net Revenue** | **$268,076** | **100%** | **$211,628** | **100%** | - Online direct-to-consumer sales constitute the vast majority of net revenue, accounting for **97%** in Q1 **2025**[34](index=34&type=chunk)
ODDITY Tech Reports Record First Quarter Results, Raises Full Year Outlook
Globenewswire· 2025-04-29 20:05
Core Insights - ODDITY Tech Ltd. reported strong financial results for Q1 2025, exceeding expectations across all metrics and raising its full-year outlook [2][3][9] - The beauty industry is undergoing significant transformation, with a shift towards online shopping and high-performance products, which ODDITY is well-positioned to capitalize on [2][5] Financial Performance - Q1 2025 net revenue reached $268 million, a 27% increase year-over-year from $212 million in Q1 2024 [4][6] - Gross profit for Q1 2025 was $201 million, up 29% from $156 million in the same quarter last year, with a gross margin of 74.9% [4][6] - Adjusted EBITDA for Q1 2025 was $52 million, representing a 9% increase from $48 million in Q1 2024 [6][31] - Net income for Q1 2025 was $38 million, compared to $33 million in Q1 2024, with an adjusted net income of $42 million [4][6] Operational Highlights - ODDITY achieved double-digit revenue growth for its brands IL MAKIAGE and SpoiledChild [5] - The company is accelerating its international expansion and progressing towards the launch of Brand 3 in Q3 and Q4 of 2025 [5][9] - ODDITY generated $87 million in free cash flow and maintained a strong balance sheet with $257 million in cash and no outstanding debt as of March 31, 2025 [5][7] Financial Outlook - ODDITY raised its 2025 financial outlook, now expecting net revenue between $790 million and $798 million, reflecting a year-over-year growth of 22% to 23% [9][11] - The company anticipates a gross margin of approximately 71% and adjusted EBITDA between $157 million and $161 million for the full year [11][12] - For Q2 2025, ODDITY projects net revenue between $235 million and $239 million, with a gross margin of 70.5% [12]
Oddity: Rare Beauty Gem
Seeking Alpha· 2025-04-19 11:00
Oddity ( ODD ) is not your average beauty retailer. It is a digital native beauty player that bypasses classical retailers and sells directly to consumers with outstanding profitability and efficiency. The key to the businessEx-hedge fund analyst with a strong interest in finding winners and losers in industries where corporate strategy matters most. I focus on analysing the market structure, competitive positioning and strategic catalysts that lead to money-making ideas in varying time horizons. Enjoy read ...
ODDITY to Announce First Quarter 2025 Financial Results on April 29, 2025
Newsfilter· 2025-04-16 20:30
Company Overview - ODDITY Tech Ltd. is a consumer tech company focused on building and scaling digital-first brands to disrupt the offline-dominated beauty and wellness industries [3] - The company serves approximately 60 million users through its AI-driven online platform, utilizing data science to identify consumer needs and develop beauty and wellness products [3] - ODDITY owns brands such as IL MAKIAGE and SpoiledChild, with headquarters in New York City, an R&D center in Tel Aviv, Israel, and a biotechnology lab in Boston [3] Upcoming Financial Results - ODDITY will release its first quarter 2025 financial results after the market close on April 29, 2025 [1] - A conference call to discuss the results will take place on April 30, 2025, at 8:30 a.m. Eastern Time [1] - Participants can access the call via specific dial-in numbers and a webcast available on the company's investor website [2]
Oddity Tech (ODD) Crossed Above the 50-Day Moving Average: What That Means for Investors
ZACKS· 2025-03-25 14:30
Technical Analysis - Oddity Tech (ODD) has surpassed resistance at the 50-day moving average, indicating a potential short-term bullish trend [1] - The 50-day simple moving average is a key indicator for traders and analysts to determine support or resistance levels [1] Performance Metrics - ODD has experienced a rally of 5.1% over the past four weeks, suggesting positive momentum [2] - The company currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [2] Earnings Estimates - There have been three upward revisions in earnings estimates for the current fiscal year, with no downward revisions in the past two months [2] - The consensus estimate for ODD has also increased, reinforcing the bullish outlook [2][3] Investment Consideration - Given the positive technical factors and earnings estimate revisions, ODD may present a potential investment opportunity for further gains in the near future [3]
Oddity Tech (ODD) Just Overtook the 20-Day Moving Average
ZACKS· 2025-03-13 14:35
Group 1 - Oddity Tech (ODD) has reached a significant support level and shows potential for investors from a technical perspective, having recently broken through the 20-day moving average, indicating a short-term bullish trend [1] - The 20-day simple moving average is a widely used trading tool that helps smooth out price fluctuations and provides more trend reversal signals than longer-term moving averages, with a price above this average indicating a positive trend [2] - ODD shares have increased by 12.4% over the past four weeks, and the company holds a Zacks Rank 3 (Hold), suggesting potential for continued gains [3] Group 2 - Positive earnings estimate revisions further strengthen the bullish outlook for ODD, with no earnings estimates lowered in the past two months and three raised estimates for the current fiscal year, leading to an increase in the consensus estimate [3] - The combination of favorable earnings estimate revisions and the stock hitting a key technical level suggests that investors should monitor ODD for potential gains in the near future [4]
Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan
Prnewswire· 2025-03-10 08:23
VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).H. Lundbeck A/S (Lundbeck) announced that amlenetug has received Orphan Drug Designation (ODD) from the MHLW in Japan.The ODD in Japan adds to other important designations: the SAKIGAKE designation by Japan's MHLW in March 2023, the Orphan Drug ...
Oddity Tech Grows 27%, Eyes New Brands
The Motley Fool· 2025-02-28 13:56
Oddity Tech (ODD -0.53%) reported its fourth-quarter and full-year 2024 earnings on February 26, 2025, highlighting strong growth and investments in future expansion. The company is seeing growth through repeat sales and its direct-to-consumer business, with new brands on the horizon in 2025 and 2026.Direct-to-Consumer Model Drives Superior PerformanceThe company's digital approach is delivering strong results amid broader industry headwinds. Oddity's direct connection with consumers enables precise invento ...